Ovarian Cancer Clinical Roundup

News Articles

(UPI/HealthDay News) June 3, 2020 - Screening for breast and ovarian cancer genes might be added to the list of medical tests that can be safely and effectively done from home, new research suggests.
(MedPage Today) June 2, 2020 - Secondary debulking surgery improved overall survival (OS) for select women with recurrent ovarian cancer in first relapse, an updated analysis from the DESKTOP III trial showed, representing the first phase III trial to demonstrate a survival benefit with such an approach.
(Markets Insider) Jun 1, 2020 - OVAL independent Data Safety Monitoring Committee (DSMC) reviewed un-blinded data and determined that the study has met the interim pre-specified criterion of an absolute percentage advantage of 10% or higher in CA-125 response in the VB-111 treated arm compared to control.
(NRG Oncology) May 29, 2020 - Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy did not improve progression-free survival (PFS) outcomes for women with platinum-sensitive ovarian cancer;, however, activity...
View all ovarian cancer news


Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and BJ Rimel, MD, Assistant Professor, Obstetrics and Gynecology, Cedars-Sinai Medical Center, discuss recent clinical studies in ovarian cancer and how recent developments are impacting the way ovarian cancer patients are treated.

Featured Ovarian Cancer Tweets

Douglas A. Levine, MD
levinemd - Jun 06  Thank you to my friends @sloan_kettering for training a talented gyn oncologist @marina_stasenko who will be joinin… https://t.co/Mk56gxi1sg

Elizabeth M. Swisher, MD
SwisherLiz - Jun 06  Thank you @ocrahope for funding our @SU2C ovarian cancer dream team with @NOCC_National and supporting our MAGENTA… https://t.co/2H2tHLUWZr